Bulletin

Investor Alert

Tokyo Markets Close in:

Currencies Europe Markets London Markets

Novartis AG ADR

NYS: NVS

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders

/marketstate/country/us

Novartis AG ADR

After Hours

NVS

/zigman2/quotes/203243705/composite

84.00

Change

-0.01 -0.01%

Volume

Volume 13,204

Mar 5, 2021, 6:52 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/203243705/composite

Previous close

$ 83.50

$ 84.01

Change

+0.51 +0.61%

Day low

Day high

$82.29

$84.24

Open: 83.36

52 week low

52 week high

$69.18

$98.52

Market cap

$186.32B

Average volume

2.04M

P/E ratio

23.76

Rev. per Employee

$462,686

EPS

3.54

Dividend

N/A

Div yield

2.61%

Ex dividend date

3/3/20

Compare:

Indexes

Dow(INDU) INDU
Nasdaq (COMP) COMP
S&P 500 (SPX) SPX
Global Dow (GDOW) GDOW

/news/latest/company/us/nvs

MarketWatch News on NVS

U.S. COVID death toll above 518,000 as Biden adds voice to outrage at Texas and Mississippi for reopening

2:35 p.m. March 4, 2021

- Ciara Linnane
Novartis Will Help Manufacture CureVac's Covid-19 Vaccine

10:17 a.m. March 4, 2021

- Josh Nathan-Kazis
Novartis agrees to help make CureVac COVID-19 vaccine

7:23 a.m. March 4, 2021

- Ciara Linnane
CureVac shares up 4% premarket

7:13 a.m. March 4, 2021

- Ciara Linnane
Novartis expects to deliver up to 50 mln doses of CureVac COVID vaccine by end 2021

7:13 a.m. March 4, 2021

- Ciara Linnane
Novartis agrees to help make CureVac COVID-19 vaccine

7:13 a.m. March 4, 2021

- Ciara Linnane
These Undervalued European Stocks Are Set to Beat Pre-Covid Earnings

4:00 a.m. March 1, 2021

- Callum Keown
Biden Marks 'Heartbreaking Milestone' of More Than 500,000 U.S. Coronavirus Deaths

10:14 a.m. Feb. 23, 2021
Blackstone Makes a Big Bet on Life Sciences

5:32 p.m. Feb. 19, 2021

- Liz Moyer
Novartis's Sandoz to buy Glaxo antibiotics unit

7:32 a.m. Feb. 11, 2021
A straightforward explanation why more COVID-19 vaccines can’t be produced with help from ‘dozens’ of companies

7:22 p.m. Feb. 3, 2021
Novartis Warns Covid-19 Sales Impact Will Last Until Mid 2021

3:50 p.m. Jan. 26, 2021

- Callum Keown
Novartis profit misses forecasts, but sales beat

1:31 a.m. Jan. 26, 2021
With Rare Speed, Gene Editing Emerges as Biotech’s New Cutting Edge

3:11 p.m. Jan. 14, 2021

- Bill Alpert
Best Income Investments for 2021

7:25 a.m. Jan. 4, 2021

- Andrew Bary
European stocks trade higher as investors welcome U.S. stimulus package and Brexit deal

9:53 a.m. Dec. 28, 2020

- Barbara Kollmeyer
European stocks tumble as countries block U.K. travel over new COVID-19 strain

7:53 a.m. Dec. 21, 2020

- Barbara Kollmeyer
As bitcoin busts out new records, these market watchers see $250,000 and even $400,000 on the horizon

1:17 p.m. Dec. 17, 2020

- Barbara Kollmeyer
Novartis to buy Cadent for up to $770 million

2:21 a.m. Dec. 17, 2020
Novartis's Beovu meets Phase-3 primary endpoint

1:54 a.m. Dec. 15, 2020
Loading more headlines...

Analyst Ratings

Analysts Raise Ratings on Teva Stock on Ajovy’s FDA Approval

11:10 a.m. Sept. 17, 2018

- MarketRealist.com
Analysts Cut Target Prices on MYL Stock after Its Q2 2018 Results

5:05 p.m. Aug. 15, 2018

- MarketRealist.com
Analysts’ Latest Recommendations on Mylan

12:06 p.m. June 27, 2018

- MarketRealist.com

/news/nonmarketwatch/company/us/nvs

Other News on NVS

Genmab: A Company With Downside Antibodies

2:28 p.m. March 7, 2021

- GuruFocus.com
Novartis (NVS) & CureVac Collaborate for COVID-19 Vaccine

10:59 a.m. March 5, 2021

- Zacks.com
Pfizer's (PFE) Lorbrena Gets FDA Nod for First-Line Lung Cancer

8:41 a.m. March 4, 2021

- Zacks.com
CureVac shares gain on COVID-19 vaccine manufacturing pact with Novartis

7:52 a.m. March 4, 2021

- Seeking Alpha
Novartis to Help Make CureVac Covid-19 Vaccine

7:01 a.m. March 4, 2021

- Jared S. Hopkins
The 91 Kiplinger 'Top Dividend Stocks On Earth' March Update

3:59 p.m. March 3, 2021

- Seeking Alpha
Illumina's Buzzing Genome Market

3:06 p.m. March 3, 2021

- Seeking Alpha
Biden Says U.S. to Have Vaccines for All Adults by End of May

7:17 a.m. March 3, 2021

- Tarini Parti
Aclaris Therapeutics: A Potential Big Pharma Deal May Be In The Horizon

4:00 p.m. March 2, 2021

- Seeking Alpha
The Buzzing Gene-Editing Market Of Crispr Therapeutics

8:54 p.m. March 1, 2021

- Seeking Alpha
10-K: CODEXIS, INC.

5:35 p.m. March 1, 2021

- Edgar Online - (EDG = 10Q, 10K)
Top Analyst Reports for Tesla, Intel & Verizon

5:08 p.m. March 1, 2021

- Zacks.com
Acceleron (XLRN) Q4 Loss Wider Than Expected, Revenues Beat

4:33 p.m. March 1, 2021

- Zacks.com
10-K: BEIGENE, LTD.

4:35 p.m. Feb. 25, 2021

- Edgar Online - (EDG = 10Q, 10K)
The TikTok 'Hit It, Get It' Stock Market

3:08 p.m. Feb. 25, 2021

- Seeking Alpha
To Make More Covid-19 Vaccines, Rival Drugmakers Team Up

7:00 a.m. Feb. 23, 2021

- Jared S. Hopkins
To Make More Covid-19 Vaccines, Rival Drugmakers Team Up

7:00 a.m. Feb. 23, 2021

- Jared S. Hopkins
ARKG: Precautionary Measures, But Transformational Objectives Remain Intact

9:23 a.m. Feb. 22, 2021

- Seeking Alpha
How ARK Invest ETFs will respond to a stock market correction, and which stocks it will sell

2:14 p.m. Feb. 20, 2021

- Seeking Alpha
Novartis Hikes Its Dividend Again, Now Yields 3.8%

11:35 a.m. Feb. 20, 2021

- Seeking Alpha
Loading more headlines...

/news/pressrelease/company/us/nvs

Press Releases on NVS

Bone Cancer Therapy Market Analysis Survey 2021 with Top Countries Data Analysis by Industry Trends, Size, Share, Company Overview, Growth, Development and Forecast | With Covid 19 Analysis

10 min ago12:35 a.m. March 8, 2021

- The Express Wire
Cancer Therapy Market Report Survey 2021 with Top Countries Data Industry Size, Growth Factors, Top Leaders, Development Strategy, Future Trends, Historical Analysis, Competitive Landscape and Regional Forecast | With Covid 19 Analysis

10 min ago12:35 a.m. March 8, 2021

- The Express Wire
Acute Myeloid Leukemia Market Growth Survey 2021 with Top Countries Data Share, Scope, Stake, Trends, Industry Size, Sales & Revenue, Growth, Opportunities and Demand with Competitive Landscape and Analysis Research Report | With Covid 19 Analysis

10 min ago12:35 a.m. March 8, 2021

- The Express Wire
Hormonal Replacement Therapy Market Growth Survey 2021 with Top Countries Data Industry Size, Share, Business Growth, Revenue, Trends, Market Demand Penetration and Forecast | With Covid 19 Analysis

10 min ago12:35 a.m. March 8, 2021

- The Express Wire
Gastric Cancer Therapy Market Analysis Survey 2021 with Top Countries Data Key Leaders Analysis, Segmentation, Growth, Future Trends, Gross Margin, Demands, Emerging Technology by Regional Forecast | With Covid 19 Analysis

10 min ago12:35 a.m. March 8, 2021

- The Express Wire
Atopic Dermatitis Market Size Survey 2021 with Top Countries Data Share, Scope, Stake, Trends, Industry Size, Sales & Revenue, Growth, Opportunities and Demand with Competitive Landscape and Analysis Research Report | With Covid 19 Analysis

10 min ago12:35 a.m. March 8, 2021

- The Express Wire
Chemoinformatics Market Size Survey 2021 with Top Countries Data Industry Share, Size, Revenue, Latest Trends, Business Boosting Strategies, CAGR Status, Growth Opportunities and Forecast | With Covid 19 Analysis

10 min ago12:35 a.m. March 8, 2021

- The Express Wire
Anti-Fungal Drugs Market Report Survey 2021 with Top Countries Data Industry Overview, Key Players Analysis, Emerging Opportunities, Comprehensive Research Study, Competitive Landscape and Potential of Industry | With Covid 19 Analysis

10 min ago12:35 a.m. March 8, 2021

- The Express Wire
Sterile Injectable Drugs Market Size 2021 Global Industry Insights by Global Share, Emerging Trends, Regional Analysis, Segments, Prime Players, Drivers, Growth Factor and Foreseen till 2026

16 min ago12:29 a.m. March 8, 2021

- The Express Wire
Myelofibrosis Treatment Market 2021 with COVID-19 impact on Industry: Growth Global Industry Size, Top manufacturers , Analysis, Share, Trends, Market Demand, Growth, Opportunities and Forecast 2026

16 min ago12:29 a.m. March 8, 2021

- The Express Wire
Diabetes Therapeutics and Diagnostics Market 2021 Segmentation and Analysis by Recent Trends, consumption by Regional data, Development, Investigation, Growth by to 2026

16 min ago12:29 a.m. March 8, 2021

- The Express Wire
Chronic Low Back Pain Treatment Market 2021–Industry Analysis, Size, Share, Trends, Market Demand, Growth, Opportunities and Forecast 2026

16 min ago12:29 a.m. March 8, 2021

- The Express Wire
Renal Cell Carcinoma Drugs Market Size - Top manufacturers , Global Industry Analysis, Market Share, Growth, Trends, Segmentation and Forecast 2026

16 min ago12:29 a.m. March 8, 2021

- The Express Wire
Cancer Supportive Care Market 2021 Top Companies report covers, Industry Outlook | In-depth Analysis Business Opportunities and Market Share,Demand Forecast to 2026

16 min ago12:29 a.m. March 8, 2021

- The Express Wire
Drug Device Combination Products Market Size in 2021 Industry Demand, Market Share, Trend, Industry News, Business Growth, Top Key Players Update till 2026

16 min ago12:29 a.m. March 8, 2021

- The Express Wire
Hospital Injectable Drugs Market 2021 Top manufacturers Records, Size, Market Share & Trends Analysis 2021-2026

16 min ago12:29 a.m. March 8, 2021

- The Express Wire
Menopause Treatment Market 2021 Production, Revenue, Growth Rate, Price and Gross Margin, Opportunities and Forecast 2026

16 min ago12:29 a.m. March 8, 2021

- The Express Wire
Oral Cancer Treatment Market Size in 2021 Industry Demand, Market Share, Trend, Industry News, Business Growth, Top Key Players Update till 2026

16 min ago12:29 a.m. March 8, 2021

- The Express Wire
Spinal Muscular Atrophy Market 2021 - Market Share, Top manufacturers , Globally Market Size and Forecast to 2026

17 min ago12:29 a.m. March 8, 2021

- The Express Wire
Global Orphan Drugs Market Size, Share Industry, Analysis, Price, Trends, Report 2020-2027

20 min ago12:26 a.m. March 8, 2021

- Comserve
Loading more headlines...

Rates »

Mortgage Equity Savings Auto

National averages from Bankrate.com

Trending Tickers

/quotes/zigman/17636479/composite VUZI+15.60%
/quotes/zigman/237947/composite JCP-5.83%
/quotes/zigman/59392505/composite NUGT-2.93%
/quotes/zigman/59386294/composite JNUG-5.94%
/quotes/zigman/65801738/composite TLT+1.11%

MarketWatch.com

Follow MarketWatch
RSS
Podcasts

Copyright © 2021 MarketWatch, Inc. All rights reserved.
By using this site, you agree to the Subscriber Agreement & Terms of Use
Privacy Notice and Cookie Notice ().
Do Not Sell My Personal Information

Intraday Data provided by FACTSET and subject to terms of use. Historical and current end-of-day data provided by FACTSET. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.

Novartis AG ADR

MarketWatch News on NVS

Analyst Ratings

Other News on NVS

Press Releases on NVS

Rates »

Latest News

dow

nasdaq

s&p 500

Kiosk